TrialScientific reports2025

Preliminary, randomized, double-blinded, placebo-controlled cross-over study with resveratrol in hypertensive patients.

Ebrahim Shafiei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.